Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results

Radhakrishnan Kavita; Di Bisceglie Adrian M.; Reddy K. Rajender; Lim Joseph K.; Levitsky Josh; Kuo Alexander; Hassan Mohamed A.; Darling Jama M.; Feld Jordan J.; Akushevich Lucy; Vainorius Monika; Nelson David R.; Fried Michael W.; Brown Robert S.; Terrault Norah

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results

【24h】

Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results

机译：肝细胞癌（HCC）的影响和肿瘤治疗对丙型肝炎直接作用抗病毒（DAA）治疗的持续病毒性反应（SVR）率的影响：HCV-靶结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2017年第1期|共2页
作者
Radhakrishnan Kavita; Di Bisceglie Adrian M.; Reddy K. Rajender; Lim Joseph K.; Levitsky Josh; Kuo Alexander; Hassan Mohamed A.; Darling Jama M.; Feld Jordan J.; Akushevich Lucy; Vainorius Monika; Nelson David R.; Fried Michael W.; Brown Robert S.; Terrault Norah;
展开▼
作者单位

Univ Calif San Francisco San Francisco CA 94143 USA;

St Louis Univ Sch Med St Louis MO USA;

Univ Penn Philadelphia PA 19104 USA;

Yale Univ Sch Med New Haven CT USA;

Northwestern Univ Chicago IL 60611 USA;

Virginia Mason Med Ctr Seattle WA 98101 USA;

Univ Minnesota Minneapolis MN USA;

Univ North Carolina Chapel Hill Chapel Hill NC USA;

Toronto Western Hosp Ctr Liver Toronto ON Canada;

Univ North Carolina Chapel Hill Chapel Hill NC USA;

Univ North Carolina Chapel Hill Chapel Hill NC USA;

Univ Florida Gainesville FL USA;

Univ North Carolina Chapel Hill Chapel Hill NC USA;

Weill Cornell Med Sch New York NY USA;

Univ Calif San Francisco San Francisco CA 94143 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results [J] . Radhakrishnan Kavita, Di Bisceglie Adrian M., Reddy K. Rajender, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：肝细胞癌（HCC）的影响和肿瘤治疗对丙型肝炎直接作用抗病毒（DAA）治疗的持续病毒性反应（SVR）率的影响：HCV-靶结果
2. Editorial: reciprocal interaction between HCV direct‐acting anti‐virals (DAA) and hepatocellular carcinoma (HCC)—a negative impact of HCC on sustained virologic response not of DAA on HCC [J] . Hollande Clémence, Pol Stanislas Alimentary pharmacology & therapeutics. . 2019,第2期

机译：编辑：HCV直接作用抗病毒（DAA）和肝细胞癌（HCC）之间的相互作用 - HCC对HCC对DAA的持续病毒性反应的负面影响
3. Rates of sustained virological response 12?weeks after the scheduled end of direct‐acting antiviral ( DAA DAA )‐based hepatitis C virus ( HCV HCV ) therapy from the National German HCV HCV registry: does HIV HIV coinfection impair the response to DAA DAA combination therapy? [J] . Bischoff J, Mauss S, Cordes C, HIV medicine . 2018,第4期

机译：持续的病毒学响应率12？周末直接作用抗病毒（DAA DAA）基于国家德国HCV HCV登记处的丙型肝炎病毒（HCV HCV）治疗后：HIV HIV辛融合损害对Daa Daa组合的反应损害治疗？
4. Predictability of Sustained Virological Response (SVR) in Patients with HCV/HIV Co-infection During Combination Therapy With Peginterferon Alfa-2A (40KD) (PEGASYS~R) Plus Ribavirin (COPEGUS~R) in the APRICOT Trial [C] . M. Rodriguez Torres, F.J. Torriani, E. Lissen International AIDS Conference . 2004

机译：HCV / HIV与Peginterferon Alfa-2a（40KD）（Pegasys〜R）加上利韦韦林（Copegus〜R）在杏试验期间HCV / HIV CONOMENT患者持续病毒学反应（SVR）的可预测性
5. Baseline Toronto HCC Risk Index (THRI) and Albumin Predict Low Risk of Hepatocellular Carcinoma (HCC) after Sustained Virological Response (SVR) in HCV Infection [D] . Lau, Jason. 2019

机译：基线多伦多HCC风险指数（THRI）和白蛋白预测HCV感染持续病毒响应（SVR）后肝细胞癌（HCC）的低风险
6. The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease [O] . Charles De Comarmond, Hendren Bajillan, Bailey Guest 2017

机译：直接作用（DAA）治疗丙型肝炎病毒（HCV）对晚期肝病患者肝细胞癌（HCC）发病率的影响
7. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? [O] . J Bischoff, S Mauss, C Cordes, 2018

机译：直接作用抗病毒（DAA）的丙型肝炎病毒（HCV）治疗的预定结束后12周持续持续的病毒学响应率：HIV繁殖会损害对DAA组合治疗的反应吗？

Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results

著录项

相似文献

相关主题

期刊订阅